Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Autoantibodies against nucleic acids and excessive type I interferon (IFN) are hallmarks of human systemic lupus erythematosus (SLE). We previously reported that SLE neutrophils exposed to TLR7 agonist autoantibodies release interferogenic DNA, which we now demonstrate to be of mitochondrial origin. We further show that healthy human neutrophils do not complete mitophagy upon induction of mitochondrial damage. Rather, they extrude mitochondrial components, including DNA (mtDNA), devoid of oxidized (Ox) residues. When mtDNA undergoes oxidation, it is directly routed to lysosomes for degradation. This rerouting requires dissociation from the transcription factor A mitochondria (TFAM), a dual high-mobility group (HMG) protein involved in maintenance and compaction of the mitochondrial genome into nucleoids. Exposure of SLE neutrophils, or healthy IFN-primed neutrophils, to antiribonucleotide protein autoantibodies blocks TFAM phosphorylation, a necessary step for nucleoid dissociation. Consequently, Ox nucleoids accumulate within mitochondria and are eventually extruded as potent interferogenic complexes. In support of the in vivo relevance of this phenomenon, mitochondrial retention of Ox nucleoids is a feature of SLE blood neutrophils, and autoantibodies against Ox mtDNA are present in a fraction of patients. This pathway represents a novel therapeutic target in human SLE.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Different cellular lineages (10–18) may extrude their mitochondria upon activation.”
From Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA (2019) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Extracellular mitochondria have been identified in damaged tissues (8, 18–20); diverse inflammatory conditions (11, 12, 14, 21–24); and in the blood of critical care patients (22).”
From Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA (2019) · cites this paper as [12]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Various cellular lineages are capable of extruding their mitochondria. Activated mast cells10, T-cells11, eosinophils12, hepatocytes13, neutrophils14–16 and platelets17,18, in addition to damaged organs or tissues7,13,19,20, release extracellular mitochondria.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“Extracellular mitochondria have been described in various clinical conditions, including trauma25,26, burn injury27, cancer28, rheumatoid arthritis17,29, systemic lupus erythematosus (SLE)15,16 and transfusion adverse reactions17,18,30,31.”
From Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations (2019) · cites this paper as [16]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several reports demonstrate that a considerable fraction of the nucleic acids contained in NETs is of mitochondrial, rather than nuclear, origin [724–728].”
From Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018. (2018) · cites this paper as [727]
Experimental — accuracy not yet measured
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neutrophil Extracellular Traps Kill Bacteria
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S., Weinrauch, Y., & Zychlinsky, A. (2004) · Science · doi:10.1126/science.1092385 · Cited by 10,268
Circulating mitochondrial DAMPs cause inflammatory responses to injury
Zhang, Q., Raoof, M., Chen, Y., Sumi, Y., Sursal, T., Junger, W., Brohi, K., Itagaki, K., & Hauser, C. J. (2010) · Nature · doi:10.1038/nature08780 · Cited by 3,812 · cited 2×
“mtDNA activates neutrophils through TLR9 engagement (Zhang et al., 2010) and, upon cytoplasmic leakage, leads to cell autonomous NLRP3 and TLR9 activation (Nakahira et al.”
BackgroundAntimicrobial Autophagy: A Conserved Innate Immune Response in Drosophila
Moy, R. H., & Cherry, S. (2013) · Journal of Innate Immunity · doi:10.1159/000350326 · Cited by 3,539
Nakahira, K., Haspel, J. A., Rathinam, V. A. K., Lee, S.-J., Dolinay, T., Lam, H. C., Englert, J. A., Rabinovitch, M., Cernadas, M., Kim, H. P., et al. (2011) · Nature Immunology · doi:10.1038/ni.1980 · Cited by 3,049 · cited 2×
“, 2010) and, upon cytoplasmic leakage, leads to cell autonomous NLRP3 and TLR9 activation (Nakahira et al., 2011; Oka et al., 2012).”
BackgroundOxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis
Shimada, K., Crother, T. R., Karlin, J., Dagvadorj, J., Chiba, N., Chen, S., Ramanujan, V. K., Wolf, A. J., Vergnes, L., Ojcius, D. M., et al. (2012) · Immunity · doi:10.1016/j.immuni.2012.01.009 · Cited by 2,282 · cited 1×
“3 A, bottom). mtDNA is highly susceptible to oxidation (Yakes and Van Houten, 1997), a proinflammatory modification (Shimada et al., 2012).”
BackgroundInterferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood
Bennett, L., Palucka, A. K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J., & Pascual, V. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021553 · Cited by 1,958 · cited 1×
“Expression of IFN- and neutrophil-related transcripts correlates with disease activity, and common allelic gene variants within these pathways confer disease susceptibility (Bennett et al., 2003; Moser et al., 2009; Bentham et al., 2015).”
BackgroundSelf-citationPlasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910 · cited 2×
“Addition of the cationic peptide LL-37 to facilitate their uptake (Lande et al., 2007) resulted in a 10fold increase in IFN-α levels in the presence of Ox mtDNA (Fig.”
BackgroundThe pathways of mitophagy for quality control and clearance of mitochondria
Ashrafi, G., & Schwarz, T. L. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2012.81 · Cited by 1,900 · cited 1×
“This process requires autophagy activation, sequestration of damaged mitochondria into autophagosomes, and fusion of autophagosomes with lysosomes (Ashrafi and Schwarz, 2013).”
BackgroundYakes, F. M., & Van Houten, B. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.514 · Cited by 1,854
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383 · cited 11×
“5 DIS CUS SION SLE neutrophils extrude interferogenic DNA when activated with anti-Sm/RNP antibodies in an FcγR, TLR7, and ROS-dependent manner (Garcia-Romo et al., 2011).”
BackgroundMethodInfluentialSelf-citation
Cited by
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Damage-associated molecular patterns in inflammatory diseases
Roh, J. S., & Sohn, D. H. (2018) · Immune Network · doi:10.4110/in.2018.18.e27 · Cited by 1,261
“Oxidized mitochondrial DNA (mtDNA) was found in the blood neutrophils of SLE patients, and extrusion of oxidized mtDNA could stimulate IFN production by activating plasmacytoid DCs (49).”
BackgroundInfluentialMitochondrial DNA in innate immune responses and inflammatory pathology
West, A. P., & Shadel, G. S. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.21 · Cited by 1,115
Mitochondrial control of inflammation
Marchi, S., Guilbaud, E., Tait, S. W. G., Yamazaki, T., & Galluzzi, L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00760-x · Cited by 1,027
Anders, H.-J., Saxena, R., Zhao, M.-H., Parodis, I., Salmon, J. E., & Mohan, C. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0141-9 · Cited by 958
Mitochondrial DNA in inflammation and immunity
Riley, J. S., & Tait, S. W. (2020) · EMBO reports · doi:10.15252/embr.201949799 · Cited by 865
“Caielli et al [87] found that in healthy neutrophils, mitochondria with oxidative damage are removed not via mito-phagy, but by extruding their mitochondrial matrix contents, including TFAM-mtDNA nucleoids, into the extracellular space.”
VDAC oligomers form mitochondrial pores to release mtDNA fragments and promote lupus-like disease
Kim, J., Gupta, R., Blanco, L. P., Yang, S., Shteinfer-Kuzmine, A., Wang, K., Zhu, J., Yoon, H. E., Wang, X., Kerkhofs, M., et al. (2019) · Science · doi:10.1126/science.aav4011 · Cited by 793
Plasmacytoid Dendritic Cells: Development, Regulation, and Function
Reizis, B. (2019) · Immunity · doi:10.1016/j.immuni.2018.12.027 · Cited by 673
Cellular Mechanisms of NETosis
Thiam, H. R., Wong, S. L., Wagner, D. D., & Waterman, C. M. (2020) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev-cellbio-020520-111016 · Cited by 605
“Several studies have shown that mtDNA can be released extracellularly and can associate with nuclear DNA on NETs (Caielli et al. 2016, Lood et al. 2016, McIlroy et al. 2014, Wang et al. 2015).”
BackgroundThe multiple pathways to autoimmunity
Theofilopoulos, A. N., Kono, D. H., & Baccala, R. (2017) · Nature Immunology · doi:10.1038/ni.3731 · Cited by 590
Molecular mechanisms of mitochondrial DNA release and activation of the cGAS-STING pathway
Kim, J., Kim, H.-S., & Chung, J. H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-00965-7 · Cited by 535
Interferon target-gene expression and epigenomic signatures in health and disease
Barrat, F. J., Crow, M. K., & Ivashkiv, L. B. (2019) · Nature Immunology · doi:10.1038/s41590-019-0466-2 · Cited by 530
Emerging views of mitophagy in immunity and autoimmune diseases
Xu, Y., Shen, J., & Ran, Z. (2020) · Autophagy · doi:10.1080/15548627.2019.1603547 · Cited by 515
Digestion of Chromatin in Apoptotic Cell Microparticles Prevents Autoimmunity
Sisirak, V., Sally, B., D’Agati, V., Martinez-Ortiz, W., Özçakar, Z. B., David, J., Rashidfarrokhi, A., Yeste, A., Panea, C., Chida, A. S., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.034 · Cited by 450
The rise of mitochondria in medicine
Picard, M., Wallace, D. C., & Burelle, Y. (2016) · Mitochondrion · doi:10.1016/j.mito.2016.07.003 · Cited by 452
“In neutrophils, mitochondrial damage may also lead to extrusion of mtDNA nucleiods, which when oxidized, can trigger interferon production and contribute to autoimmune processes in lupus (Caielli et al., 2016).”
BackgroundPicca, A., Calvani, R., Coelho-Junior, H. J., Landi, F., Bernabei, R., & Marzetti, E. (2020) · Antioxidants · doi:10.3390/antiox9080647 · Cited by 437
“In this context, circulating mtDNA is increasingly acknowledged as a pivotal mediator linking mitochondrial dysfunction to inflammation [30,34,35].”
BackgroundMitochondria Know No Boundaries: Mechanisms and Functions of Intercellular Mitochondrial Transfer
Torralba, D., Baixauli, F., & Sánchez-Madrid, F. (2016) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00107 · Cited by 440
“Neutrophils can extrude mitochondrial components, specifically oxidized mitochondrial nucleoids, which boost type I interferon secretion and can lead to the development of lupus (Caielli et al., 2016).”
Boeltz, S., Amini, P., Anders, H.-J., Andrade, F., Bilyy, R., Chatfield, S., Cichon, I., Clancy, D. M., Desai, J., Dumych, T., et al. (2019) · Cell Death & Differentiation · doi:10.1038/s41418-018-0261-x · Cited by 431
Mitochondrial Damage-Associated Molecular Patterns: From Inflammatory Signaling to Human Diseases
Grazioli, S., & Pugin, J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00832 · Cited by 411
“brought some insights on the mechanism regulating mtDNA extracellular release in neutrophils (60).”
BackgroundNeutrophils in Homeostasis, Immunity, and Cancer
Nicolás-Ávila, J. Á., Adrover, J. M., & Hidalgo, A. (2017) · Immunity · doi:10.1016/j.immuni.2016.12.012 · Cited by 403
“Alterations in the normal mitochondrial disposal in neutrophils from SLE patients and release of oxidized mitochondrial nucleoids can also drive interferon production and generation of autoantigens (Caielli et al., 2016).”
BackgroundPathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets
Crow, M. K. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2022-223741 · Cited by 398
Torralba, D., Baixauli, F., Villarroya-Beltri, C., Fernández-Delgado, I., Latorre-Pellicer, A., Acín-Pérez, R., Martín-Cófreces, N. B., Jaso-Tamame, Á. L., Iborra, S., Jorge, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05077-9 · Cited by 375
Neutrophil phenotypes and functions in cancer: A consensus statement
Quail, D. F., Amulic, B., Aziz, M., Barnes, B. J., Eruslanov, E., Fridlender, Z. G., Goodridge, H. S., Granot, Z., Hidalgo, A., Huttenlocher, A., et al. (2022) · Journal of Experimental Medicine · doi:10.1084/jem.20220011 · Cited by 340
Mitochondrial DNA Release in Innate Immune Signaling
Newman, L. E., & Shadel, G. S. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-032620-104401 · Cited by 318
“■ Ox-mtDNA is a component of NETs and triggers type I IFN when released (50–52).”
BackgroundXu, M. M., Pu, Y., Han, D., Shi, Y., Cao, X., Liang, H., Chen, X., Li, X.-D., Deng, L., Chen, Z. J., et al. (2017) · Immunity · doi:10.1016/j.immuni.2017.07.016 · Cited by 315
“More recently, the release of oxidized mtDNA with potent interferongenic properties has been observed during NETosis (neutrophil extracellular traps) and caspase-inhibited apoptosis (Caielli et al., 2016; Laguette et al., 2014; Lood et al., 2016; Rongvaux et al., 2014).”
BackgroundInfluentialRole of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja-Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 307
Kato, Y., Park, J., Takamatsu, H., Konaka, H., Aoki, W., Aburaya, S., Ueda, M., Nishide, M., Koyama, S., Hayama, Y., et al. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-212988 · Cited by 304
Type I Interferons in Autoimmune Disease
Crow, M. K., Olferiev, M., & Kirou, K. A. (2019) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043952 · Cited by 291
Cell-Free DNA as a Biomarker in Autoimmune Rheumatic Diseases
Duvvuri, B., & Lood, C. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00502 · Cited by 282
“Given recent studies implicating mitochondrial extrusion in the SLE pathogenesis (38, 88), we expect upcoming studies to demonstrate increased mtDNA levels also in SLE patients.”
BackgroundInfluentialCaielli, S., Veiga, D. T., Balasubramanian, P., Athale, S., Domic, B., Murat, E., Banchereau, R., Xu, Z., Chandra, M., Chung, C.-H., et al. (2019) · Nature Medicine · doi:10.1038/s41591-018-0254-9 · Cited by 263
Self-citationNeutrophil extracellular traps in cancer
Cristinziano, L., Modestino, L., Antonelli, A., Marone, G., Simon, H.-U., Varricchi, G., & Galdiero, M. R. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.07.011 · Cited by 245
Macrophage fumarate hydratase restrains mtRNA-mediated interferon production
Hooftman, A., Peace, C. G., Ryan, D. G., Day, E. A., Yang, M., McGettrick, A. F., Yin, M., Montano, E. N., Huo, L., Toller-Kawahisa, J. E., et al. (2023) · Nature · doi:10.1038/s41586-023-05720-6 · Cited by 242
“Autoantibodies to dsRNA, as well as dsDNA, have been detected in patients with SLE 61,62 .”
Konig, M. F., & Andrade, F. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00461 · Cited by 241
“Different to NETosis, neutrophils remain alive while releasing ox-mtDNA in the extracellular space, gDNA is not released, and the process is dependent on mtROS, but not NADPH oxidase (19) (Figure 4).”
BackgroundResultInfluentialThe role of neutrophil extracellular traps in rheumatic diseases
Apel, F., Zychlinsky, A., & Kenny, E. F. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0039-z · Cited by 234
Molecular Mechanisms of mtDNA-Mediated Inflammation
De Gaetano, A., Solodka, K., Zanini, G., Selleri, V., Mattioli, A. V., Nasi, M., & Pinti, M. (2021) · Cells · doi:10.3390/cells10112898 · Cited by 230
Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE
Caielli, S., Cardenas, J., de Jesus, A. A., Baisch, J., Walters, L., Blanck, J. P., Balasubramanian, P., Stagnar, C., Ohouo, M., Hong, S., et al. (2021) · Cell · doi:10.1016/j.cell.2021.07.021 · Cited by 228
Self-citationSystemic Lupus Erythematosus Pathogenesis: Interferon and Beyond
Caielli, S., Wan, Z., & Pascual, V. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-101921-042422 · Cited by 224
Self-citationDrury, B., Hardisty, G., Gray, R. D., & Ho, G.-T. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.03.002 · Cited by 222
Immunometabolism in systemic lupus erythematosus
Morel, L. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.43 · Cited by 219
Barrera, M.-J., Aguilera, S., Castro, I., Carvajal, P., Jara, D., Molina, C., González, S., & González, M.-J. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102867 · Cited by 213
Lee-Kirsch, M. A. (2017) · Annual Review of Medicine · doi:10.1146/annurev-med-050715-104506 · Cited by 210
Bioactive DNA from extracellular vesicles and particles
Malkin, E. Z., & Bratman, S. V. (2020) · Cell Death & Disease · doi:10.1038/s41419-020-02803-4 · Cited by 211
“In 2016, two groups demonstrated the in fl ammatory potential of mtDNA in the context of SLE 12,86 .”
InfluentialSoni, C., Perez, O. A., Voss, W. N., Pucella, J. N., Serpas, L., Mehl, J., Ching, K. L., Goike, J., Georgiou, G., Ippolito, G. C., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.04.015 · Cited by 204
Mitochondrial DNA and TLR9 drive muscle inflammation upon Opa1 deficiency
Rodríguez‐Nuevo, A., Díaz‐Ramos, A., Noguera, E., Díaz‐Sáez, F., Duran, X., Muñoz, J. P., Romero, M., Plana, N., Sebastián, D., Tezze, C., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201796553 · Cited by 207
“…interferogenic mtDNA by a process dependent in part on lysosomal activity and that occurs in the presence of a constitutive defect in mitophagy (Caielli et al , 2016), Based on the observations that OPA1 mutations cause mtDNA instability (Kim et al , 2005; Amati-Bonneau et al , 2008; Hudson et…”
Fueling Inflamm-Aging through Mitochondrial Dysfunction: Mechanisms and Molecular Targets
Picca, A., Lezza, A., Leeuwenburgh, C., Pesce, V., Calvani, R., Landi, F., Bernabei, R., & Marzetti, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18050933 · Cited by 200
“The modulation of TFAM binding to mtDNA seems to be relevant during inflammation, as suggested by the involvement of TFAM in rerouting oxidized mtDNA to lysosomes for degradation in neutrophils [14].”
BackgroundInfluentialMitochondrial dysfunction as a trigger of innate immune responses and inflammation
West, A. P. (2017) · Toxicology · doi:10.1016/j.tox.2017.07.016 · Cited by 200
Cell Death and Inflammation: The Role of Mitochondria in Health and Disease
Picca, A., Calvani, R., Coelho-Junior, H. J., & Marzetti, E. (2021) · Cells · doi:10.3390/cells10030537 · Cited by 198
“Dysmorphic, hyper-fused or hyper-fragmented mitochondrial phenotypes have been observed in several diseases characterized by inflammation and mtDNA release [5,6,14,34,35].”
BackgroundMitochondrial-derived vesicles in metabolism, disease, and aging
König, T., & McBride, H. M. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.11.014 · Cited by 183
Neutrophil extracellular trap formation requires OPA1-dependent glycolytic ATP production
Amini, P., Stojkov, D., Felser, A., Jackson, C. B., Courage, C., Schaller, A., Gelman, L., Soriano, M. E., Nuoffer, J.-M., Scorrano, L., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05387-y · Cited by 194
Circulating mitochondrial DNA is an early indicator of severe illness and mortality from COVID-19
Scozzi, D., Cano, M., Ma, L., Zhou, D., Zhu, J. H., O’Halloran, J. A., Goss, C. W., Rauseo, A. M., Liu, Z., Sahu, S. K., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.143299 · Cited by 186
“For example, human neutrophils following activation extrude their MT-DNA due to an inability to complete mitophagy (37).”
BackgroundMitochondrial function in development and disease
Rossmann, M. P., Dubois, S. M., Agarwal, S., & Zon, L. I. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048912 · Cited by 184
“In SLE, oxidized nucleoids (see Box 2) accumulate within mitochondria until the proinflammatory, interferogenic mtDNA is released (Caielli et al., 2016; Lood et al., 2016).”
BackgroundTrumpff, C., Michelson, J., Lagranha, C. J., Taleon, V., Karan, K. R., Sturm, G., Lindqvist, D., Fernström, J., Moser, D., Kaufman, B. A., et al. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.04.002 · Cited by 177
Wiens, K. E., & Ernst, J. D. (2016) · PLOS Pathogens · doi:10.1371/journal.ppat.1005809 · Cited by 176
“Additionally, systemic lupus erythematosus is associated with mitochondrial dysregulation and type I interferon signatures [38–40], oxidized mtDNA released from lupus neutrophils drives type I interferon [24], and mitochondrial antioxidants attenuate IFNβ responses and lupus-like disease in mice [30].”
Pathways leading to an immunological disease: systemic lupus erythematosus
Zharkova, O., Celhar, T., Cravens, P. D., Satterthwaite, A. B., Fairhurst, A.-M., & Davis, L. S. (2017) · Rheumatology · doi:10.1093/rheumatology/kew427 · Cited by 172
Inter and Intracellular mitochondrial trafficking in health and disease
Shanmughapriya, S., Langford, D., & Natarajaseenivasan, K. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101128 · Cited by 171
“Neutrophils can extrude mitochondrial components including specifically oxidized mitochondrial nucleoids (Caielli et al., 2016).”
BackgroundAdvances in the understanding of mitochondrial DNA as a pathogenic factor in inflammatory diseases
Boyapati, R. K., Tamborska, A., Dorward, D. A., & Ho, G.-T. (2017) · F1000Research · doi:10.12688/f1000research.10397.1 · Cited by 169
Netting Neutrophils Activate Autoreactive B Cells in Lupus
Gestermann, N., Di Domizio, J., Lande, R., Demaria, O., Frasca, L., Feldmeyer, L., Di Lucca, J., & Gilliet, M. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700778 · Cited by 168
“As a result, mitochondrial DNA accumulates as oxidized DNA that is highly interferogenic upon expulsion (24).”
BackgroundUntangling “NETosis” from NETs
Yousefi, S., Stojkov, D., Germic, N., Simon, D., Wang, X., Benarafa, C., & Simon, H. (2019) · European Journal of Immunology · doi:10.1002/eji.201747053 · Cited by 162
Mitochondrial DNA as an inflammatory mediator in cardiovascular diseases
Nakayama, H., & Otsu, K. (2018) · Biochemical Journal · doi:10.1042/bcj20170714 · Cited by 160
Mitochondrial Dysfunction and Aging: Insights from the Analysis of Extracellular Vesicles
Picca, A., Guerra, F., Calvani, R., Bucci, C., Lo Monaco, M. R., Bentivoglio, A. R., Coelho-Júnior, H. J., Landi, F., Bernabei, R., & Marzetti, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040805 · Cited by 159
“In neutrophils, blockade of TFAM-mediated rerouting of oxidized mtDNA to lysosomes is followed by extrusion of oxidized nucleoids that eventually trigger interferon I activation [88].”
BackgroundMohanty, A., Tiwari-Pandey, R., & Pandey, N. R. (2019) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-019-00507-9 · Cited by 154
Neutrophil and remnant clearance in immunity and inflammation
Singhal, A., & Kumar, S. (2021) · Immunology · doi:10.1111/imm.13423 · Cited by 172
Mitochondria-derived cell-to-cell communication
Dache, Z. A. A., & Thierry, A. R. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112728 · Cited by 172
Neutrophils in Physiology and Pathology
Aroca-Crevillén, A., Vicanolo, T., Ovadia, S., & Hidalgo, A. (2024) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathmechdis-051222-015009 · Cited by 170
Mitochondrial Nucleoid: Shield and Switch of the Mitochondrial Genome
Lee, S. R., & Han, J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/8060949 · Cited by 150
“For example, oxidized mtDNA is degraded by lysosomes; however, oxidized mitochondrial nucleoids are not degraded via the lysosomal pathway in neutrophils in human lupus, resulting in activation of type I interferon production [121].”
BackgroundAutoimmune diseases and atherosclerotic cardiovascular disease
Porsch, F., & Binder, C. J. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01045-7 · Cited by 163
Plasmacytoid dendritic cell biology and its role in immune‐mediated diseases
Ye, Y., Gaugler, B., Mohty, M., & Malard, F. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1139 · Cited by 181
Early cellular mechanisms of type I interferon-driven susceptibility to tuberculosis
Kotov, D. I., Lee, O. V., Fattinger, S. A., Langner, C. A., Guillen, J. V., Peters, J. M., Moon, A., Burd, E. M., Witt, K. C., Stetson, D. B., et al. (2023) · Cell · doi:10.1016/j.cell.2023.11.002 · Cited by 156
“NETs are DNA-rich products of neutrophils and may act as ligands for TLR9 on the pDCs, as described in mouse and human autoimmunity 32,33,62,94 .”
Acute psychological stress increases serum circulating cell-free mitochondrial DNA
Trumpff, C., Marsland, A. L., Basualto-Alarcón, C., Martin, J. L., Carroll, J. E., Sturm, G., Vincent, A. E., Mosharov, E. V., Gu, Z., Kaufman, B. A., et al. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.03.026 · Cited by 147
“sociated with elevated ccf-mtDNA (Caielli et al., 2016), and the antiinflammatory mediator acetylcholine may prevent mtDNA release from mitochondria (Lu et al.”
Boyapati, R. K., Dorward, D. A., Tamborska, A., Kalla, R., Ventham, N. T., Doherty, M. K., Whitfield, P. D., Gray, M., Loane, J., Rossi, A. G., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy095 · Cited by 145
Picca, A., Lezza, A. M. S., Leeuwenburgh, C., Pesce, V., Calvani, R., Bossola, M., Manes-Gravina, E., Landi, F., Bernabei, R., & Marzetti, E. (2018) · Rejuvenation Research · doi:10.1089/rej.2017.1989 · Cited by 144
“Indeed, TFAM has been involved in rerouting oxidized mtDNA to lysosomes for degradation in neutrophils.(16) The extrusion of oxidized nucleoids by neutrophils in SLE represents a powerful immune system activator.”
BackgroundInfluentialPD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus
Han, X., Vesely, M. D., Yang, W., Sanmamed, M. F., Badri, T., Alawa, J., López-Giráldez, F., Gaule, P., Lee, S. W., Zhang, J.-P., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aax1159 · Cited by 136
Mechanisms of mitochondrial DNA escape and its relationship with different metabolic diseases
Pérez-Treviño, P., Velásquez, M., & García, N. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165761 · Cited by 138
Emerging Role of Mitochondrial DNA as a Major Driver of Inflammation and Disease Progression
Zhong, F., Liang, S., & Zhong, Z. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.10.008 · Cited by 137
Advances in the Pathogenesis and Treatment of Systemic Lupus Erythematosus
Accapezzato, D., Caccavale, R., Paroli, M. P., Gioia, C., Nguyen, B. L., Spadea, L., & Paroli, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076578 · Cited by 183
Gkirtzimanaki, K., Kabrani, E., Nikoleri, D., Polyzos, A., Blanas, A., Sidiropoulos, P., Makrigiannakis, A., Bertsias, G., Boumpas, D. T., & Verginis, P. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.09.001 · Cited by 133
Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus
Hartl, J., Serpas, L., Wang, Y., Rashidfarrokhi, A., Perez, O. A., Sally, B., Sisirak, V., Soni, C., Khodadadi‐Jamayran, A., Tsirigos, A., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201138 · Cited by 144
The immunology of systemic lupus erythematosus
Tsokos, G. C. (2024) · Nature Immunology · doi:10.1038/s41590-024-01898-7 · Cited by 160
“Specifically, mitochondrial DNA released from red blood cells 140 , platelets 141 and neutrophils 142 is increased in the circulation of individuals with SLE and contributes to disease pathogenesis.”
Neutrophil Extracellular Traps Exacerbate Ischemic Brain Damage
Li, C., Xing, Y., Zhang, Y., Yan, H., Jian, H., & Bai, Y. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02635-z · Cited by 142
Type I interferons in host defence and inflammatory diseases
Crow, M. K., & Rönnblom, L. (2019) · Lupus Science & Medicine · doi:10.1136/lupus-2019-000336 · Cited by 142
“23 142 143 Neutrophils Release of interferogenic oxidised mitochondrial DNA.”
InfluentialThe non-haemostatic role of platelets in systemic lupus erythematosus
Linge, P., Fortin, P. R., Lood, C., Bengtsson, A. A., & Boilard, É. (2018) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2018.38 · Cited by 142
IRGM1 links mitochondrial quality control to autoimmunity
Rai, P., Janardhan, K. S., Meacham, J. M., Madenspacher, J. H., Lin, W.-C., Karmaus, P. W. F., Martinez, J., Li, Q., Yan, M., Zeng, J., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00859-0 · Cited by 134
Platelets release mitochondrial antigens in systemic lupus erythematosus
Melki, I., Allaeys, I., Tessandier, N., Lévesque, T., Cloutier, N., Laroche, A., Vernoux, N., Becker, Y., Benk-Fortin, H., Zufferey, A., et al. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aav5928 · Cited by 125
“Given that mtDNA release by neutrophils is reported to occur concomitantly with NETosis (30, 31), we verified the presence of NETs in the same patients.”
BackgroundInfluentialIngelsson, B., Söderberg, D., Strid, T., Söderberg, A., Bergh, A.-C., Loitto, V., Lotfi, K., Segelmark, M., Spyrou, G., & Rosén, A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1711950115 · Cited by 123
“(44) who suggested that release of mtDNA requires fusion of mitochondrial membranes with plasma membrane.”
InfluentialBengtsson, A. A., & Rönnblom, L. (2017) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2017.10.003 · Cited by 140
Buang, N., Tapeng, L., Gray, V., Sardini, A., Whilding, C., Lightstone, L., Cairns, T. D., Pickering, M. C., Behmoaras, J., Ling, G. S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22312-y · Cited by 118
The source of cell-free mitochondrial DNA in trauma and potential therapeutic strategies
Thurairajah, K., Briggs, G. D., & Balogh, Z. J. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0954-3 · Cited by 124
“postulated that this phenomenon occurs when neutrophils are unable to degrade damaged mitochondria through mitophagy [40].”
BackgroundUpdate on mitochondria and muscle aging: All wrong roads lead to sarcopenia
Picca, A., Calvani, R., Bossola, M., Allocca, E., Menghi, A., Pesce, V., Lezza, A. M. S., Bernabei, R., Landi, F., & Marzetti, E. (2018) · Biological Chemistry · doi:10.1515/hsz-2017-0331 · Cited by 116
“The accumulation of severely damaged mitochondria in the context of defective mitophagy has been shown to induce the extrusion of several components able to stimulate inflammation (Caielli et al., 2016).”
BackgroundImmunopathogenesis of systemic lupus erythematosus: An update
Arnaud, L., Chasset, F., & Martin, T. (2024) · Autoimmunity Reviews · doi:10.1016/j.autrev.2024.103648 · Cited by 144
Oxidized mitochondrial DNA induces gasdermin D oligomerization in systemic lupus erythematosus
Miao, N., Wang, Z., Wang, Q., Xie, H., Yang, N., Wang, Y., Wang, J., Kang, H., Bai, W., Wang, Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36522-z · Cited by 125
Mechanisms underlying sex differences in autoimmunity
Fairweather, D., Beetler, D. J., McCabe, E. J., & Lieberman, S. M. (2024) · Journal of Clinical Investigation · doi:10.1172/jci180076 · Cited by 147
STING, the Endoplasmic Reticulum, and Mitochondria: Is Three a Crowd or a Conversation?
Smith, J. A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.611347 · Cited by 122
“In support of this mechanism, oxidized mtDNA autoantibodies were present in a fraction of patients and oxidized mtDNA nucleoids visualized in SLE patient neutrophils (139).”
BackgroundInfluentialNeutrophil Extracellular Traps, Angiogenesis and Cancer
Poto, R., Cristinziano, L., Modestino, L., de Paulis, A., Marone, G., Loffredo, S., Galdiero, M. R., & Varricchi, G. (2022) · Biomedicines · doi:10.3390/biomedicines10020431 · Cited by 136
Carlos, D., Costa, F. R. C., Pereira, C. A., Rocha, F. A., Yaochite, J. N. U., de Oliveira, G. G., Carneiro, F. S., Tostes, R. C., Ramos, S. G., Zamboni, D. S., et al. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00164 · Cited by 118
“org February 2017 | Volume 8 | Article 164 have mitochondrial retention of oxidized nucleoids, indicating that a defect in degradation of neutrophil oxidized mDNA might contribute to SLE pathogenesis (50).”
BackgroundIn vivo evidence for extracellular DNA trap formation
Yousefi, S., Simon, D., Stojkov, D., Васильевна, К. А., Karaulov, A. V., & Simon, H. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2497-x · Cited by 121
“The circulating autoantibodies such as anti-damaged-DNA/RNA ribonucleoprotein antibody immune complexes (RNP-ICs-Ab) can further activate neutrophils, including NET formation (not shown) 13, 73, 74 , leading to vicious cycle of chronic inflammation in genetically susceptible individuals 68, 74 , causing autoimmune dis…”
BackgroundBryant, J. D., Lei, Y., VanPortfliet, J. J., Winters, A. D., & West, A. P. (2022) · Current Protocols · doi:10.1002/cpz1.372 · Cited by 117
Infection with the dengue RNA virus activates TLR9 signaling in human dendritic cells
Lai, J., Wang, M., Huang, C., Wu, C., Hung, L., Yang, C., Ke, P., Luo, S., Liu, S., & Ho, L. (2018) · EMBO Reports · doi:10.15252/embr.201846182 · Cited by 114
Mitophagy in the pathogenesis and management of disease
Wang, Q., Sun, Y., Li, T. Y., & Auwerx, J. (2026) · Cell Research · doi:10.1038/s41422-025-01203-7 · Cited by 103
“266 Patients with SLE exhibit reduced expression of mitophagy-related genes, which correlates with disease severity.”
Noncanonical Cell Fate Regulation by Bcl-2 Proteins
Chong, S. J. F., Marchi, S., Petroni, G., Kroemer, G., Galluzzi, L., & Pervaiz, S. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.03.004 · Cited by 107
Review: Cell Death, Nucleic Acids, and Immunity
Elkon, K. B. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40452 · Cited by 108
“Mitochondrial DNA has recently received much attention as an agonist capable of stimulating type I IFNs and other cytokines (34,38).”
Background
Metadata
- Authors
- Caielli, S., Athale, S., Domic, B., Murat, E., Chandra, M., Banchereau, R., Baisch, J., Phelps, K., Clayton, S., Gong, M., Wright, T., Punaro, M., Palucka, K., Guiducci, C., Banchereau, J., & Pascual, V.
- Affiliations
- Baylor Institute for Immunology Research, Dallas, TX 75204 1
- The University of Texas Southwestern Medical Center (US)
- Dynavax Technologies (United States) (US)
- Texas Scottish Rite Hospital for Children (US)
- The Jackson Laboratory for Genomic Medicine (US)
- Corresponding author
- Pascual, Virginia
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2016-04-18
- Volume
- 213
- Issue
- 5
- Pages
- 697-713
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC4854735
- OpenAlex
- W2338241371
- Cited by
- 501
- References
- 52
- Citations by year
- 2026: 41 · 2025: 46 · 2024: 64 · 2023: 64 · 2022: 55 · 2021: 44 · 2020: 42 · 2019: 45 · 2018: 49 · 2017: 33 · 2016: 17
- FWCI
- 51.08
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- National Institutes of Health (P50 AR054083-01, U19 AI082715)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Life Sciences › Immunology and Microbiology › Immunology › Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Keywords
- systemic lupus erythematosus, type I interferon, neutrophils, mitochondrial DNA, mitochondrial nucleoids, mitophagy, autoantibodies, lysosomal degradation, autoinflammation, therapeutic target
- MeSH terms
- Adolescent, Autoantibodies, Child, Child, Preschool, DNA-Binding Proteins, DNA, Mitochondrial, Female, Humans, Interferon Type I, Lupus Erythematosus, Systemic, Male, Mitochondria, Neutrophils, Oxidation-Reduction, Transcription Factors, Mitochondrial Proteins, Toll-Like Receptor 7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.